Applied Filters
Associations lobby WHO to build COVID-19 IP pool
Numerous associations and individuals have come together to ask the World Health Organization to build a global pool for IP rights related to the COVID-19 pandemic.
Canada authorises compulsory licences for COVID-19 shortfalls
Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.
Novartis and others in ‘unprecedented’ COVID-19 partnership
A consortium of life sciences companies including Novartis, Bristol Myers Squibb and GSK have united to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19.
Abbott scores case-ending sanctions against wholesaler
Medical device maker Abbott has secured a series of case-ending sanctions against a wholesaler, bringing the five-year-long dispute to a close.
Costa Rica asks WHO to create voluntary COVID-19 IP pool
The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.
Ventilator maker offers up IP to tackle shortage
UK engineering company Smiths Group is making the IP covering one of its ventilators available to other manufacturers, as part of an industry attempt to tackle the shortage of life-saving equipment.
Fortress offers licences after COVID-19 testing patent backlash
Labrador Diagnostics, a subsidiary of Fortress Investment Group, has offered royalty-free licences to third parties for its patent-protected diagnostics technology, just days after suing US-based health startup BioFire, which is attempting to develop COVID-19 testing kits.
Abbott unit secures injunction against Edwards
An English High Court judge has issued an injunction against Edwards Lifesciences, handing a victory to Abbott Laboratories subsidiary Evalve.
Texas uni wants Supreme Court to settle state sovereignty rules
The University of Texas has asked the Supreme Court to rule that state-owned institutions should escape the normal rules determining the appropriate venue for filing patent lawsuits.
Thermo Fisher to buy Qiagen for $11.5bn
Biotech Thermo Fisher Scientific has announced plans to acquire Dutch diagnostics group Qiagen for $11.5 billion.
